{
  "meta": {
    "title": "Emerging_And_Re-Emerging_Infections",
    "url": "https://brainandscalpel.vercel.app/emerging-and-re-emerging-infections-9db53366.html",
    "scrapedAt": "2025-11-29T18:34:45.970Z"
  },
  "questions": [
    {
      "id": 1659,
      "choices": [
        {
          "id": 6631,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">11 February 2020</span></span></p>"
        },
        {
          "id": 6632,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">21 February 2020</span></span></p>"
        },
        {
          "id": 6633,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">11 March 2020</span></span></p>"
        },
        {
          "id": 6634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">21 March 2020</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a global health seminar, a medical student is learning about the timeline of significant events in the COVID-19 pandemic. One of the key moments in the pandemic was when the World Health Organization (WHO) officially declared COVID-19 as a pandemic. This declaration had substantial implications for public health responses worldwide. The student is asked to recall the specific date on which WHO made this declaration. On what date did the World Health Organization (WHO) declare COVID-19 as a pandemic?</span></span></p>",
      "unique_key": "Q1406785",
      "question_audio": null,
      "question_video": null,
      "map_id": 34206,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. 11 March 2020</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>COVID-19</strong> since its <strong>first detection</strong> in <strong>China,</strong> spread to over <strong>200 countries</strong>/territories. COVID-19.&nbsp;The <strong>World Health Organization</strong> (WHO) declared <strong>COVID-19</strong> as a <strong>pandemic</strong> on <strong>March 11, 2020.</strong> This declaration was a response to the <strong>rapid global spread</strong> and severe impact of the virus<strong>, signaling</strong> a <strong>heightened level</strong> of <strong>concern</strong> and the need for countries <strong>worldwide</strong> to <strong>take urgent and aggressive action</strong> to <strong>control the spread of the virus</strong>.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>January 30, 2020</strong> - <strong>WHO</strong> declared <strong>COVID-19</strong> a <strong>Public Health Emergency</strong> of <strong>International Concern</strong>, not a pandemic. </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>February 11, 2020</strong> - The disease caused by the <strong>novel coronavirus</strong> was officially named <strong>COVID-19</strong> by <strong>WHO.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>December 08, 2020</strong>: <strong>First dose</strong> of <strong>Covid vaccine</strong> administered <strong>globally</strong> (in United Kingdom)</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Indian</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>30 January 2020</strong>: India reports its <strong>First cases of COVID-19</strong> from <strong>Thrissur, Kerala</strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>25 March 2020</strong>: <strong>Nation-wide lockdown</strong> imposed</span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>16 January 2021</strong>: <strong>First </strong>dose of <strong>Covid vaccine</strong> administered in <strong>India</strong>; <strong>India </strong>begins one of the <strong>world&rsquo;s biggest COVID-19 vaccination</strong> programs</span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>December 2021</strong>: DGCI approves <strong>Covaxin </strong>for use in <strong>12-18 years old children</strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>December 2021</strong>: <strong>Booster drive</strong>, <strong>15-18 years old children</strong> vaccination drive announced</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">According to CDC (<strong>Centre for Disease Control</strong>) &ldquo;<strong>Pandemic </strong>is an <strong>epidemic spread</strong> over <strong>several countries</strong> or <strong>continents</strong>, usually <strong>affecting</strong> a <strong>large number of people</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>World Health Organization</strong> (WHO) declared <strong>COVID-19</strong> as <strong>a pandemic</strong> on <strong>March 11, 2020. </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 191)</strong></span></span></p>",
      "correct_choice_id": 6633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1661,
      "choices": [
        {
          "id": 6639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rota virus</span></span></p>"
        },
        {
          "id": 6640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rubella</span></span></p>"
        },
        {
          "id": 6641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Meningococcal meningitis</span></span></p>"
        },
        {
          "id": 6642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hepatitis B</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical student, studying for a public health exam, is reviewing the National Immunisation Schedule. While familiarizing themselves with the various vaccines included in the schedule, the student is also trying to identify vaccines that are not typically part of this standard schedule but may be recommended in certain specific situations or risk groups. Understanding what is and isn&#39;t included in the national schedule is essential for future clinical practice, especially in pediatrics and family medicine. Which of the following vaccines is NOT typically included in the National Immunisation Schedule?</span></span></p>",
      "unique_key": "Q3059042",
      "question_audio": null,
      "question_video": null,
      "map_id": 34208,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Meningococcal meningitis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Vaccination</strong> for <strong>Meningococcal meningitis</strong> is <strong>not</strong> included in <strong>National Immunisation schedule (NIS)</strong> of <strong>India.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Rota virus:</strong> &nbsp;<strong>3 doses</strong> at <strong>6, 10 and 14 weeks</strong> under NIS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Rubella</strong>: (<strong>MR</strong> vaccine) <strong>2 doses</strong> at <strong>9 months</strong> and <strong>16-24 months</strong> under NIS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Hepatitis B</strong>: <strong>4 doses</strong> at <strong>Birth, 6, 10 and 14 weeks</strong> under NIS.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">NEW National Immunization Schedule (NIS) 2023-24</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Georgia,serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-125017_3PDctN8.png\" style=\"height:1129px; width:1000px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>JE vaccine</strong> only in <strong>Endemic districts.</strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>HiB Vaccine</strong> introduced as <strong>Pentavalent vaccine</strong> &ndash; DPT + HepB + HiB vaccine in 16 states</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>fIPV</strong> is <strong>fractionated intradermal</strong> at <strong>6 weeks &amp; 14 weeks</strong> or <strong>IPV Intramuscular</strong> only at <strong>14 weeks.</strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Rotaviral vaccine</strong> introduced in <strong>9 States</strong> &ndash; Andhra Pradesh, Haryana, Himachal Pradesh, Odisha, Madhya Pradesh, Assam, Rajasthan, Tamil Nadu and Tripura.</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Measles-Rubella</strong> (MR) vaccine started from 5 States/UTs - Karnataka, Tamil Nadu, Goa, Lakshadweep and Puducherry.</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Pneumococcal conjugate vaccine</strong> PCV introduced in all 12 districts of Himachal Pradesh, 6 districts of Uttar Pradesh and 17 districts of Bihar.</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Adult JE Vaccine</strong> introduced in <strong>31 high burden districts</strong> from Assam, Uttar Pradesh and West Bengal for <strong>adult JE vaccination</strong> in the age-group of <strong>15-65 years.</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Georgia,serif\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Textbook of Community Medicine- Rajvir Bhalwar (4<sup>th</sup> edition) (page 756)</strong></span></span></strong></span></span></p>",
      "correct_choice_id": 6641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1663,
      "choices": [
        {
          "id": 6647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">North Kerelia project</span></span></p>"
        },
        {
          "id": 6648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">MONICA</span></span></p>"
        },
        {
          "id": 6649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oslow</span></span></p>"
        },
        {
          "id": 6650,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">MRFIT</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical resident, specializing in cardiology, is attending a seminar on the changing trends in coronary heart disease (CHD) over the years. The seminar highlights how shifts in socio-economic status and advancements in science and technology have impacted the patterns and prevalence of CHD globally. One of the key points of discussion is a significant project carried out by the World Health Organization (WHO) to study these changing trends in CHD. The resident is interested in knowing the specific project initiated by WHO for this purpose. Which project was carried out by the World Health Organization (WHO) to elucidate the changing trends in coronary heart disease (CHD) in light of evolving socio-economic conditions and technological advancements?</span></span></p>",
      "unique_key": "Q3559387",
      "question_audio": null,
      "question_video": null,
      "map_id": 34209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. MONICA</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>WHO MONICA</strong> Project is designed to <strong>measure</strong> the trends in <strong>mortality</strong> and <strong>morbidity</strong> from <strong>Coronary heart disease</strong> (CHD) and <strong>stroke</strong>, and to <strong>assess</strong> the <strong>extent</strong> to which they are related to changes in <strong>known risk factors</strong> in <strong>different</strong> <strong>populations</strong> in <strong>27 countries</strong> (10 years period).</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>reasons</strong> for the <strong>changing trends</strong> in <strong>CHD</strong> are <strong>not precisely known</strong>.&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. North Kerelia project:</strong> <strong>Risk factor</strong> <strong>intervention</strong> trial aimed to <strong>reduce cardiovascular risk</strong> factor levels and to <strong>promote early diagnosis, treatment</strong> and <strong>rehabilitation of patients</strong>. The result showed the <strong>reduction of CHD deaths</strong> in <strong>10 years.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Oslow</strong>: <strong>Oslow diet/smoking intervention</strong> study aimed to <strong>determine</strong> if <strong>serum lipids lowering</strong> and <strong>smoking-cessation</strong> would <strong>reduce incidence</strong> of first attack of <strong>CHD</strong> in <strong>40-50 yrs males</strong>. The result showed that there is <strong>reduction</strong> of <strong>MI by 47%.</strong>&nbsp;With this study, <strong>primary prevention of CHD</strong> entered <strong>practical field</strong> of <strong>preventive medicine</strong> in an <strong>impressive manner.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. MRFIT: </strong>&nbsp;<strong>Multiple risk factor intervention trial</strong>, The <strong>study aim</strong> was to <strong>reduce cardiovascular risk factor levels</strong> (<strong>smoking, high BP,</strong> <strong>hypercholesterolemia</strong>). The study showed the <strong>non-significant reduction</strong>&nbsp;seen in <strong>CHD</strong> <strong>deaths</strong> in <strong>10</strong> <strong>years.</strong>&nbsp;<br />\r\n&nbsp;&nbsp;&nbsp;&nbsp;&ndash; <strong>Interpretation</strong>: Control group was <strong>not</strong> properly chosen (<strong>changed habits</strong> and <strong>lifestyle</strong> to an extent <strong>not anticipated</strong> by <strong>designers of trial</strong>)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Project</strong> that was <strong>carried </strong>out by the <strong>World Health Organization (WHO)</strong> to <strong>elucidate</strong> the changing trends in <strong>coronary heart disease (CHD)</strong> in light of evolving <strong>socio-economic conditions</strong> and <strong>technological advancements</strong> - <strong>MONICA</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> ed pg 413.</strong></span></span></p>",
      "correct_choice_id": 6648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1680,
      "choices": [
        {
          "id": 6715,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">27 January 2014</span></span></p>"
        },
        {
          "id": 6716,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">27 February 2014</span></span></p>"
        },
        {
          "id": 6717,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">27 March 2014</span></span></p>"
        },
        {
          "id": 6718,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">27 April 2014</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A medical student, preparing for a presentation on public health achievements, is researching significant milestones in the eradication of infectious diseases. One of the notable successes discussed is India&#39;s achievement in polio eradication. The student needs to pinpoint the year when India was officially certified as polio-free, which represents a major public health triumph. In which year was India officially certified as polio-free?</span></span></p>",
      "unique_key": "Q5089316",
      "question_audio": null,
      "question_video": null,
      "map_id": 34205,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. 27 March 2014</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>India</strong> was declared &lsquo;<strong>POLIO-FREE&rsquo;</strong> on <strong>27 March 2014</strong> by <strong>WHO</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Poliomyelitis 2023</strong>&nbsp;[No case has been reported in India from 13 January 2011 onwards] -&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">No. of Polio cases: ZERO</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">No. of Vaccine derived Polio virus (VDPV) cases: Zero</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">No. of AFP cases: 9150</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Non-polio AFP rate: 5.79</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Some Important Pointers related to Poliomyelitis &ndash;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em>Causative agent</em></strong><em>: </em><strong>Poliovirus</strong> (serotypes 1, 2 and 3)</span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>P1</strong> is <strong>MCC</strong> of <strong>epidemics</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>P2</strong> is <strong>most antigenic</strong> and most <strong>easily eradicable</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>P3</strong> is <strong>MCC</strong> of <strong>VAPP</strong> (Vaccine associated paralytic poliomyelitis) &ndash; <strong>1 per 2.7 million chance</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em>Reservoir: </em>Man</strong> (<strong>No chronic carriers</strong>)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">MC clinical occurrence: <strong>Subclinical cases&nbsp;</strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">For every <strong>1 clinical case</strong> of <strong>polio</strong>: there are <strong>1000 subclinical cases</strong> in <strong>children</strong> and <strong>75 subclinical </strong>cases in <strong>adults</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em>Infectious material</em></strong><em>: </em><strong>Faeces and oro-pharyngeal secretions</strong> </span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">(Polio diagnosis<strong>: Isolation</strong> of <strong>wild poliovirus</strong> from <strong>stool</strong> is the recommended method). <strong>Virus</strong> usually can be <strong>found</strong> in the <strong>feces</strong> from <strong>onset to up to &lt; 8 weeks</strong> after <strong>paralysis</strong>, with the <strong>highest probability</strong>&nbsp;of detection during the <strong>first 2 weeks</strong> from <strong>onset of Paralysis</strong>.</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><em>Period of <strong>communicability: </strong></em><strong>7-10 days before and after</strong> onset of symptoms</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><em>Risk factors for <strong>precipitation </strong>of an attack:</em></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fatigue</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Trauma</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intramuscular injections</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Operative procedures (<strong>Tonsillectomy</strong>) esp. in <strong>epidemics of polio</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Administration of <strong>Alum </strong>containing <strong>DPT vaccine</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em>Incubation period</em></strong><em>: </em><strong>3 &ndash; 35 days</strong> (usually<strong> 7 &ndash; 14 days</strong>)</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>India</strong> was declared <strong>&lsquo;POLIO-FREE&rsquo;</strong> on <strong>27 March 2014 </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 236)</strong></span></span></p>",
      "correct_choice_id": 6717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1692,
      "choices": [
        {
          "id": 6763,
          "text": "<p><span style=\"font-size:12pt;\">1 AFP case for every 100000 children under 15 years of age.</span></p>"
        },
        {
          "id": 6764,
          "text": "<p><span style=\"font-size:12pt;\">1 AFP case for every 1000 children under 15 years of age.</span></p>"
        },
        {
          "id": 6765,
          "text": "<p><span style=\"font-size:12pt;\">1 AFP case for every 200000 children under 15 years of age.</span></p>"
        },
        {
          "id": 6766,
          "text": "<p><span style=\"font-size:12pt;\">1 AFP case for every 10000 children under 15 years of age.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A medical consultant working with a non-governmental organization (NGO) is involved in a project focused on assessing the surveillance capacity for poliomyelitis (polio) in various regions. A critical aspect of this project is the analysis of the reporting rate of acute flaccid paralysis (AFP) cases, which serves as a key surveillance indicator for polio. Accurate detection and reporting of AFP cases are essential for monitoring potential polio outbreaks and guiding eradication efforts. The consultant is tasked with reviewing and understanding the established guidelines for AFP case detection to ensure the efficacy of the surveillance program. What are the established guidelines for detecting AFP cases as part of polio surveillance?</span></p>",
      "unique_key": "Q9853079",
      "question_audio": null,
      "question_video": null,
      "map_id": 34207,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. 1 AFP case for every 100000 children under 15 years of age.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The number of <strong>AFP cases</strong> reported <strong>each year</strong> is used as an <strong>indicator</strong> of a <strong>country's ability</strong> to <strong>detect polio</strong> - even in countries where the <strong>disease no longer occurs</strong>. A <strong>country's surveillance system</strong> needs to be <strong>sensitive</strong> enough to <strong>detect at least</strong> <strong>one </strong>case of <strong>AFP</strong> for every <strong>100,000 children</strong> under <strong>15,</strong> even in the absence of <strong>polio.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Surveillance Indicators -&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-113435.png\" alt=\"\" width=\"1000\" height=\"1252\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acute Flaccid Paralysis (AFP) Surveillance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Nationwide AFP</strong> (acute flaccid paralysis) surveillance is the <strong>gold standard</strong> for detecting cases of <strong>poliomyelitis</strong>. The <strong>four steps</strong> of surveillance are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Finding and reporting children</strong> with <strong>acute flaccid paralysis (AFP)</strong></span></li><li><span style=\"font-size:12pt;\">Transporting <strong>stool samples</strong> for <strong>analysis</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Isolating and identifying</strong> <strong>poliovirus</strong> in the <strong>laboratory</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Mapping </strong>the virus to determine the origin of the <strong>virus strain.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">(All reported cases of <strong>AFP </strong>should be investigated by <strong>DIO </strong>‘within <strong>48 hours’</strong> after <strong>notification</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Available <strong>diagnostic</strong> <strong>tests</strong> for <strong>Poliomyelitis </strong>–</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Stool examination (recommended in every case of AFP)</span></li><li><span style=\"font-size:12pt;\">CSF examination</span></li><li><span style=\"font-size:12pt;\">Throat examination</span></li><li><span style=\"font-size:12pt;\">Blood examination</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acute Flaccid Paralysis</strong> (AFP): <strong>Acute onset</strong> (<strong>&lt; 4 weeks</strong>) in a child aged <strong>&lt;15 years</strong>, or any case of <strong>paralytic illness</strong> in a person of any age when <strong>polio is suspected.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Acute</strong>: <strong>rapid progression</strong> of from <strong>onset to maximum paralysis.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Flaccid</strong>: <strong>loss of muscle tone</strong>, ‘<strong>floppy’</strong> as opposed to <strong>spastic or rigid.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Paralysis</strong>: <strong>weakness</strong>, <strong>loss of voluntary movement.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Differential diagnosis</strong> of AFP:<strong> Descending</strong> <strong>asymmetric flaccid LMN paralysis</strong></span><ul><li><span style=\"font-size:12pt;\"><strong>Guillain Barre Syndrome</strong> (Cytologico-albuminic dissociation).</span></li><li><span style=\"font-size:12pt;\"><strong>Transverse myelitis</strong> (Normal CSF, sensory loss +, bladder dysfunction +).</span></li><li><span style=\"font-size:12pt;\"><strong>Traumatic neuritis</strong> (any age, only one leg involved).</span></li><li><span style=\"font-size:12pt;\">Other<strong> Non-polio enteric viruses</strong>: <strong>Coxsackie-B</strong>, <strong>ECHO, Enterovirus type 70 and 71, Mumps.</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A <strong>country's surveillance</strong> system needs to be <strong>sensitive</strong> enough to <strong>detect</strong> at <strong>least</strong> <strong>one case of AFP</strong> for every <strong>100,000 children</strong> under <strong>15</strong>, even in the <strong>absence</strong> of <strong>polio</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Park 26<sup>th</sup> edition (page 237)</strong></span></p>",
      "correct_choice_id": 6763,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2017,
      "choices": [
        {
          "id": 8061,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Chloride – 65 mmol/ litre</span></p>"
        },
        {
          "id": 8062,
          "text": "<p><span style=\"font-size:12pt;\">Citrate – 10 mmol/ litre</span></p>"
        },
        {
          "id": 8063,
          "text": "<p><span style=\"font-size:12pt;\">Potassium – 10 mmol/ litre</span></p>"
        },
        {
          "id": 8064,
          "text": "<p><span style=\"font-size:12pt;\">Sodium – 75 mmol/ litre</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A medical intern is conducting a session for healthcare workers on the management of dehydration in diarrheal diseases, emphasizing the use of Oral Rehydration Solutions (ORS). The session includes a discussion on the composition of reduced osmolarity ORS, which is designed to be more effective and have fewer side effects than standard ORS formulations. The intern is aware of some common misconceptions about the composition of reduced osmolarity ORS and aims to address these during the session. Which of the following statements about the composition of reduced osmolarity ORS is NOT correct?</span></p>",
      "unique_key": "Q1827420",
      "question_audio": null,
      "question_video": null,
      "map_id": 34204,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Potassium – 10 mmol/litre</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct answer is <strong>Potassium – 20 mmol/ litre&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chloride – 65 mmol/ litre. Correct&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Citrate – 10 mmol/ litre. Correct&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sodium – 75 mmol/ litre. Correct&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Reduced osmolarity ORS:&nbsp;Total osmolarity - 245 mmol/ litre</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Comparison of different types of ORS solutions<strong> -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture32_SCVUL8k.jpg\" alt=\"\" width=\"1000\" height=\"752\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>WHO</strong> <strong>Reduced Osmolarity ORS</strong> contains (in mmol/L) - <strong>Sodium 75,</strong> <strong>Potassium 20</strong>, <strong>Chloride 65</strong>, <strong>Citrate 10</strong>,<strong>Glucose 75;</strong> <strong>Total Osmolar</strong> <strong>concentration </strong>is <strong>245 mmol/L.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Ratio of Sodium</strong>: <strong>Glucose</strong> in <strong>WHO</strong> Reduced Osmolarity ORS - <strong>1 : 1</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Park 26<sup>th</sup> edition (page 261)</strong></span></p>",
      "correct_choice_id": 8063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}